Alprazolam Pregnancy and Breastfeeding Warnings
Alprazolam Pregnancy Warnings
Alprazolam has been assigned to pregnancy category D by the FDA. An increased risk of congenital malformations in humans has been suggested with use of other benzodiazepines, although small studies have not implicated alprazolam. Withdrawal symptoms have been described in neonates whose mothers took alprazolam during pregnancy. There are no controlled data in human pregnancy. Alprazolam use is considered contraindicated during pregnancy.
Physicians are encouraged to register patients before fetal outcome is known (e.g., ultrasound, results of amniocentesis, etc) into the Antiepileptic Drug (AED) Pregnancy Registry at 1-888-233-2334 or 1-888-AED-AED4. This is an ongoing study at the Massachusetts General Hospital/Harvard Medical School. This study is designed to monitor the outcomes of pregnant women exposed to antiepileptic drugs in order to determine which therapies are associated with increased risk.
Alprazolam Breastfeeding Warnings
Chronic administration of another benzodiazepine, diazepam, to nursing mothers has been reported to cause their infants to become lethargic and lose weight.
Alprazolam is probably excreted into human milk in small amounts. Withdrawal symptoms have been described in nursing infants whose mothers have withdrawn from alprazolam. The manufacturer recommends that, as a general rule, nursing should not be undertaken by mothers who must use alprazolam.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.